Summary: Researchers find that a non-drug based treatment approach called acute intermittent hypoxia (AIH), which consists of short periods of reduced oxygen, reduces inflammation, protects nerve fibres, and promotes repair in mice with multiple sclerosis-like disease. While the findings of this study are promising, further research will need to assess whether this treatment has the same effect in people with MS.
(more…)Tag: Videos
-
Episode 116 BEaTS Research Radio- Interview with Dr. Michael Hildebrand
Nicole Chu from the University of Ottawa speaks with Dr. Mike Hildebrand, Associate Professor at Carleton University in the Department of Neuroscience and Affiliate Investigator at the Ottawa Hospital Research Institute. Tune in to learn more about their recent work published in the Journal Brain which demonstrates for the first time that spinal cord process pain signals differently in women compared to men.
Learn more: https://hildebrandpainlab.com/
Follow BEaTS Research Radio on youtube https://www.youtube.com/@BEaTSResearchRadio
-
In this episode of Brain Bytes we meet with Aarthi Gobinath, PhD. She was curious about what depression looks like in the female brain and how postpartum depression manifests itself. She hopes her work can tackle the issue of researchers commonly using only male test subjects in their studies. Links: Voluntary running influences the efficacy of fluoxetine in a model of postpartum depression. https://www.ncbi.nlm.nih.gov/pubmed/2… Follow Brain Bytes on Twitter! @UBCBrainBytes https://twitter.com/UBCBrainBytes Aarthi Gobinath on Twitter: @aarthigobinath https://twitter.com/aarthigobinath Michael Ruffolo on Twitter: @mike_ruffolo https://twitter.com/mike_ruffolo Brain Bytes is a science communication initiative by graduate students within the Neuroscience Program at the University of British Columbia, in collaboration with the Graduate School of Journalism.
-
On April 15, 2023, neuroscientists at the Djavad Mowafaghian Centre for Brain Health showcased their research in areas such as healthy aging, dementia, mental health, brain injury, Parkinson’s disease and autism, highlighting ways UBC is leading the way in improving the lives of British Columbians and what some of the next discoveries in brain health might be.
Speakers:
- Drs. Lynn Raymond and Shernaz Bamji (Overview of the Centre)
- Dr. Teresa Liu-Ambrose (Healthy Aging)
- Dr. Mark Cembrowski (Learning/Memory and Dementias)
- Dr. Cheryl Wellington (Brain Injury and Repair)
- Dr. Fidel Vila-Rodriguez (Mental Health and Addictions)
- Dr. Kurt Haas (Brain Development and Neurodevelopmental Disorders)
- Dr. Silke Appel-Cresswell (Sensory/Motor Systems and Movement Disorders)
-
With 1 in 5 Canadians experience mental illness, Dr. Liisa Galea explores how women are disproportionately affected, and how we can help.
Co-hosted by Melissa Grelo, Cynthia Loyst, Lainey Lui and correspondent Jess Allen, THE SOCIAL, airing on CTV, brings a fresh, daily perspective on the up-to-the-minute news, pop culture, and lifestyle topics that matter most to Canadians.
-
Lisa Saksida, PhD, holds the Canada Research Chair in Translational Cognitive Neuroscience, Tier 1. She studies the brain’s capacity for learning, memorizing and paying attention. Through mapping the neural pathways in a healthy brain, Saksida and her team can better understand the effects of neurodegenerative disorders.
She dares to ask: how can understanding the neurobiology of cognition lead to new treatments for brain disorders?
Saksida is a Professor of Physiology & Pharmacology at the Schulich School of Medicine & Dentistry, a scientist at the Robarts Research Institute, and the Scientific Director of BrainsCAN. She has diverse expertise in psychology, robotics and artificial intelligence, and computer sciences.
Daring to Ask is a series that profiles Canada Research Chairs and Endowed Research Chairs at Schulich Medicine & Dentistry. These researchers are advancing knowledge in their respective fields, asking and answering questions that challenge that status quo and seeking to improve patient care. It is essential research made possible by generous donors and the investment of funding agencies.
Learn more about the important research at the Robarts Research Institute – Western University
-
“For advancing the molecular and genomic understanding of brain tumours, leading to better ways of discriminating, classifying and managing brain tumour subtypes with potential to transform the clinical care of the disease.“
Gairdner FoundationCongratulations to Dr. Gelareh Zadeh, MD, PhD, FRCS(C), FAANS, who is the Dan Family Chair and Professor of Neurosurgery, University of Toronto on winning a 2023 Canada Gairdner Momentum Award!
Dr. Gelareh Zadeh is a neurosurgeon and senior scientist who combines her in-depth clinical knowledge of brain cancer with clinical and translational research to improve the diagnosis and management of adult brain tumours.
Dr. Zadeh’s research program applies advanced genomic and epigenomic profiling to further our understanding of the molecular regulators of brain tumours and to develop tools that can refine biomarkers of diagnosis to predict treatment responses and ultimately, improve patient outcomes.
Learn more about Dr. Zadeh’s work on the Gairdner award website: https://www.gairdner.org/winner/gelareh-zadeh
[su_youtube_advanced url=”https://www.youtube.com/watch?v=maMytT8NjAw” rel=”no” modestbranding=”yes”]
-
UCalgary clinical trial maps how we learn motor skills, and the results could be a game-changer for stroke rehabilitation.
This morning, you probably reached out of bed to turn off your alarm clock, and later brushed your teeth or buttoned a shirt. Those movements are routine; mundane, even. You are long past the point of wondering how you learned to do any of those things and don’t give a second thought to the complexity of what happened in your brain so that your arm could lift your cup of coffee. (more…)
-
Public lecture recorded Wed, May 11, 2022 – 5:30 PM – 7:00 PM EDT
Learn from experts about focused ultrasound, a revolutionary technology with the potential to transform the treatment of brain diseases. Focused ultrasound is a revolutionary technology with the potential to change medicine and transform the treatment of brain diseases. The innovative procedure aims to do away with traditional invasive brain surgeries and instead relies on precision imaging and ultrasound energy to reach areas deep within the brain for the treatment, or investigation of safety and efficacy in a number of indications including; essential tremor, Alzheimer’s disease, severe depression, and more. At Sunnybrook Health Sciences Centre, researchers have advanced focused ultrasound technology, pioneering applications and leading ground-breaking clinical trials to provide new therapies for brain diseases, in some cases where none existed before. In this CAN Public Lecture, Sunnybrook’s world-leading experts will share the latest advances in focused ultrasound — from device development, to biological insights and clinical translation.
Co-Organizers Canadian Association for Neuroscience & Sunnybrook Health Sciences Centre
Speakers
- Dr. Kullervo Hynynen
- Dr. Isabelle Aubert
- Dr. Nir Lipsman
Host Dr. Carol Schuurmans
Q&A Moderators: Dr. Rikke Kofoed & Dr. Yacine Touahri
Learn more about Focused ultrasound research at Sunnybrook Health Sciences Centre
Learn more about the speakers, host and moderators on the Canadian Association for Neuroscience website
